IntelGenx

IntelGenx is a leading supplier to the pharmaceutical industry, providing a range of innovative solutions aimed at enhancing drug development and delivery. The company specializes in the 505(b)(2) application, which allows for an abbreviated new drug application, offering a streamlined pathway to market for new formulations. Their expertise is further demonstrated through services such as accelerated stability studies and analytical services, catering to both human and animal health sectors. IntelGenx operates as a Contract Development and Manufacturing Organization (CDMO), delivering comprehensive support from process development to manufacturing and handling controlled substances. Their focus on oral drug delivery, alongside advancements in transdermal and transmucosal systems, reinforces their commitment to providing effective drug delivery technologies.

Services include:
- 505(b)(2)
- Accelerated Stability Studies
- Analytical Services
- Animal Health
- Contract Development and Manufacturing (CDMO)
- Drug Delivery Devices
- Process Development
- Manufacturing
- Controlled Substances
- Oral Drug Delivery
- R&D Services
- Stability Studies
- Transdermals/Transmucosals

IntelGenx is dedicated to providing cutting-edge pharmaceutical solutions that meet the evolving needs of the industry. For further information about their services and capabilities, please visit intelgenx.com.